1-4 of 4
Daniel Leger, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Determination of the Efficacy of Epigenetic Therapy in High Risk Myeloid Disease Using the Zebrafish Model

Adam Deveau, BSc, MSc, Alexander Michael Forrester, BSc, PhD, Andrew J Coombs, BScH, Gretchen S Wagner, BScH, Clemens Grabher, PhD, Ian Chute, MSc, Daniel Leger, MSc, Stephen Lewis, PhD, Matthew Mingay, BSc, Martin Hirst, PhD, A. Thomas Look, MD, Jason N. Berman, MD
Journal: Blood
Blood (2014) 124 (21): 436.
https://doi.org/10.1182/blood.V124.21.436.436
Published: 2014
Journal Articles

Epigenetic Therapy Inhibits NUP98-HOXA9 -Mediated Myeloid Disease – Decitabine and Valproic Acid Work Synergistically to Rescue Normal Hematopoiesis in Transgenic Zebrafish.

Adam Deveau, BSc(Hons), A. Michael Forrester, PhD, Clemens Grabher, Andrew J Coombs, BSc(Hon), Ian Chute, MSc, Daniel Leger, MSc, Stephen Lewis, PhD, A. Thomas Look, M.D., Jason N Berman, MD
Journal: Blood
Blood (2012) 120 (21): 2391.
https://doi.org/10.1182/blood.V120.21.2391.2391
Published: 2012
Journal Articles

Using the Zebrafish As a Tool for Modeling Systemic Mastocytosis,

Tugce B Balci, MD, Andrew J Coombs, BSc(Hon), Chloe Grondin, Sahar I Da'as, MSc, Ian Chute, MSc, Daniel Leger, MSc, Adolfo A. Ferrando, MD, PhD, Stephen Lewis, PhD, Jason N Berman, MD
Journal: Blood
Blood (2011) 118 (21): 3208.
https://doi.org/10.1182/blood.V118.21.3208.3208
Published: 2011
Journal Articles

NUP98-HOXA9 drives High-Risk Myeloid Disease in Zebrafish – An In Vivo platform to Study Interacting Genes and Perform Drug Discovery,

A. Michael Forrester, BSc(Hon), Andrew J Coombs, BSc(Hon), Eileen R McBride, MD, FRCP(C), Ian Chute, MSc, Daniel Leger, MSc, Stephen Lewis, PhD, Clemens Grabher, PhD, Thomas Look, MD, Jason N Berman, MD
Journal: Blood
Blood (2011) 118 (21): 3622.
https://doi.org/10.1182/blood.V118.21.3622.3622
Published: 2011